LOADING
Tag: Blocker
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study – BioSpace
September 5, 2025
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study BioSpace Source link
chat_bubble0 Comment
visibility86 Views
IL-13 Blocker Beats Atopic Dermatitis
January 11, 2023
Lebrikizumab, an investigational interleukin (IL)-13 inhibitor seeking to join an increasingly crowded market for atopic dermatitis treatments, effectively reduced symptoms of the condition (a.k.a. eczema) when combined with topical corticosteroids, researchers reported. In a randomized trial called ADhere — one of three phase III studies that developers Eli Lilly and Almirall have completed for the […]
chat_bubble0 Comment
visibility286 Views